We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

  • Cookie
    cookieyes-consent
  • Duration
    1 Year
  • Description

    Saves your cookie preferences

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

  • Cookie
    _ga_KHMF2KCS20
  • Duration
    2 years
  • Description

    Google Analytics cookie used to persist session state.

  • Cookie
    _ga
  • Duration
    2 Years
  • Description

    Google Analytics cookie used to distinguish users.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Skip to main content
Company News

This morning, Dr Weiss presented our Phase 3 data at @EASL | The Home of Hepatology’s International Liver Congress 2021.

By June 25, 2021April 5th, 2024No Comments

Friday 25 June

Today we are excited to announce positive top-line data from our Phase 3 head-to-head trial of trientine tetrahydrochloride and d-penicillamine.

This is the first trial of its kind comparing against the only approved first-line treatment of Wilson’s Disease, d-penicillamine, in more than 70 years.

Dr Karl Heinz Weiss will be presenting this data today at 8.45-9am CEST as part of @EASL | The Home of Hepatology’s International Liver Congress 2021.

Orphalan SA Logo

Healthcare Professionals

The page you are about to enter is intended for Healthcare Professionals. Please confirm that you are a Healthcare Professional.

Cancel
Yes, I Am A Healthcare Provider